IN2012DN01577A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01577A
IN2012DN01577A IN1577DEN2012A IN2012DN01577A IN 2012DN01577 A IN2012DN01577 A IN 2012DN01577A IN 1577DEN2012 A IN1577DEN2012 A IN 1577DEN2012A IN 2012DN01577 A IN2012DN01577 A IN 2012DN01577A
Authority
IN
India
Prior art keywords
relates
present
attenuated
cells
preparation
Prior art date
Application number
Inventor
Marigliano Martine
Reymund Jacqueline
Sainte-Marie Martine
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of IN2012DN01577A publication Critical patent/IN2012DN01577A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The present invention relates to an enzymatic composition for the digestion of chicken embryos intended to the preparation of cells which are used for the production of viruses. The present invention also relates to a method for producing a wild type, an attenuated and/or a recombinant virus comprising a step of preparation of cells from chicken embryos using an enzymatic composition of the invention. The present invention relates to a purified wild type, attenuated and/or recombinant virus obtained and to a pharmaceutical composition, preferably a vaccine, comprising said virus for the treatment and/or the prevention a cancer, an infectious disease and/or an autoimmune disorder, and uses thereof.
IN1577DEN2012 2009-07-21 2010-07-21 IN2012DN01577A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09305690 2009-07-21
US26429909P 2009-11-25 2009-11-25
PCT/EP2010/004478 WO2011009613A1 (en) 2009-07-21 2010-07-21 Enzymatic composition for the digestion of chicken embryos

Publications (1)

Publication Number Publication Date
IN2012DN01577A true IN2012DN01577A (en) 2015-06-05

Family

ID=43498784

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1577DEN2012 IN2012DN01577A (en) 2009-07-21 2010-07-21

Country Status (13)

Country Link
US (1) US20120190100A1 (en)
EP (1) EP2456461A1 (en)
JP (1) JP2012533311A (en)
KR (1) KR20120089245A (en)
CN (1) CN102939100A (en)
AU (1) AU2010275764A1 (en)
CA (1) CA2768562A1 (en)
IN (1) IN2012DN01577A (en)
MX (1) MX2012000979A (en)
RU (1) RU2012106760A (en)
SG (1) SG178090A1 (en)
TW (1) TW201109440A (en)
WO (1) WO2011009613A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2627425A4 (en) * 2010-10-11 2014-11-05 Abbvie Inc Processes for purification of proteins
WO2014009276A1 (en) 2012-07-09 2014-01-16 Roche Diagnostics Gmbh Recombinantly produced neutral protease originating from paenibacillus polymyxa
CN104818238B (en) * 2015-03-26 2019-12-20 四川农业大学 Chicken intestine epithelial cell separation culture method
EP3298139B1 (en) 2015-05-19 2021-09-15 Scientific Protein Laboratories LLC Method for reducing or inactivating viral and microbial content in the processes for the manufacture of pancreatin
CN105316309A (en) * 2015-12-04 2016-02-10 广州赛莱拉干细胞科技股份有限公司 Digestive enzyme composition and preparation method of fibroblasts and feeder layer cells
CN109957545A (en) * 2017-12-26 2019-07-02 江苏艾尔康生物医药科技有限公司 A method of digestion RPE cell
BR112020014727A2 (en) * 2018-01-19 2020-12-08 Kolon Life Science, Inc. RECOMBINANT VACCINIA VIRUS AND PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME
CA3098565A1 (en) 2018-04-29 2019-11-07 Claire G. ZHANG Scalable clarification process for recombinant aav production
CN115927162A (en) * 2019-03-08 2023-04-07 中国人民解放军军事科学院军事医学研究院 Method for obtaining sweat gland organoids by culturing sweat gland cells and its application
CN111117947B (en) * 2020-01-09 2022-03-08 电子科技大学 Rapid separation method of cyprinid liver-like cells
CN112458040B (en) * 2020-12-23 2022-07-05 四川农业大学 A method for isolating and culturing adult yak rumen epithelial cells
CN113136412A (en) * 2021-04-22 2021-07-20 浙江珂瑞康生物医疗科技有限公司 Biological load determination treatment liquid for biomedical material containing soluble protein
CN117512055B (en) * 2023-11-17 2024-08-23 广州元信生物科技有限公司 Liver tissue dissociation kit and dissociation method thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072565A (en) * 1974-11-04 1978-02-07 The Dow Chemical Company Production of viruses in tissue culture without use of serum
US4675187A (en) 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
FR2643817B1 (en) 1989-03-06 1993-12-17 Transgene Sa PHARMACEUTICAL COMPOSITION, USEFUL AS A PREVENTIVE OR CURATIVE AGAINST TUMORS INDUCED BY PAPILLOMAVIRUS
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
GB9001641D0 (en) 1990-01-24 1990-03-21 Imp Cancer Res Tech Compounds
FR2668064B1 (en) 1990-10-23 1994-12-16 Transgene Sa PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF MALIGNANT TUMOR.
EP0710288B1 (en) 1993-06-10 2006-04-05 Genetic Therapy, Inc. Adenoviral vectors for treatment of hemophilia
FR2710536B1 (en) 1993-09-29 1995-12-22 Transgene Sa Anti-cancer use of a viral vector comprising a gene which modulates the immune and / or inflammatory response.
FR2751879B1 (en) 1996-07-30 1998-10-30 Transgene Sa PHARMACEUTICAL COMPOSITION AGAINST TUMORS AND PAPILLOMAVIRUS INFECTIONS
FR2766091A1 (en) 1997-07-18 1999-01-22 Transgene Sa ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION
FR2777570A1 (en) 1998-04-17 1999-10-22 Transgene Sa Novel mutant enzyme and related fusion proteins, useful for gene therapy of cancer, by prodrug activation
ES2305514T5 (en) 2002-09-05 2019-06-14 Bavarian Nordic As Method for the amplification of a poxvirus in serum-free conditions
FR2855758B1 (en) 2003-06-05 2005-07-22 Biomerieux Sa COMPOSITION COMPRISING NS3 / NS4 POLYPROTEIN AND HCV NS5B POLYPEPTIDE, EXPRESSION VECTORS INCLUDING THE CORRESPONDING NUCLEIC SEQUENCES AND THEIR USE IN THERAPEUTICS
JP4672659B2 (en) 2003-07-21 2011-04-20 トランジェーヌ、ソシエテ、アノニム Polypeptide having improved cytosine deaminase activity
AU2003267841A1 (en) * 2003-09-29 2005-04-14 Seong Jun Yoon Highly bioactive and productive chicken embryo extract and method for preparation thereof
US8187878B2 (en) * 2004-08-13 2012-05-29 University Of Georgia Research Foundation, Inc. Methods for increasing definitive endoderm differentiation of pluripotent human embryonic stem cells with PI-3 kinase inhibitors
WO2006052826A2 (en) * 2004-11-05 2006-05-18 The Government Of The United States Of America As Represented By The Secretary Methods for preparing cells and viruses
NZ563603A (en) 2005-04-29 2010-10-29 Innovative Dairy Products Pty A method for producing stem cells or stem cell-like cells from mammalian embryos
BRPI0710242A2 (en) 2006-04-21 2011-08-09 Transgene Sa use of a composition
DK2029756T3 (en) 2006-06-20 2017-02-13 Transgene Sa PROCEDURE FOR PREPARING POXVIRA AND POXVIRUS COMPOSITIONS
GB0613756D0 (en) * 2006-07-12 2006-08-23 Univ Sheffield Cell culture medium

Also Published As

Publication number Publication date
CN102939100A (en) 2013-02-20
WO2011009613A1 (en) 2011-01-27
EP2456461A1 (en) 2012-05-30
JP2012533311A (en) 2012-12-27
RU2012106760A (en) 2013-08-27
CA2768562A1 (en) 2011-01-27
AU2010275764A2 (en) 2012-03-15
AU2010275764A1 (en) 2012-03-15
SG178090A1 (en) 2012-03-29
TW201109440A (en) 2011-03-16
MX2012000979A (en) 2012-06-08
KR20120089245A (en) 2012-08-09
US20120190100A1 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
IN2012DN01577A (en)
BR112013011194A2 (en) rabies virus-like glycoprotein particles (vlps).
CY1121159T1 (en) NON-INTEGRATED LINTER BODIES
WO2011000566A3 (en) Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections
MX342995B (en) METHODS OF GENERATING NATURAL MURDER CELLS.
CR20110641A (en) METHOD FOR THE PRODUCTION AND PURIFICATION OF ORTHOPOXVIRUS
PH12015501953A1 (en) Substituted nucleotide analogs
TN2011000628A1 (en) Production of polio virus at high titres for vaccine production
NZ629582A (en) Production of fmdv-resistant livestock by allele substitution
CY1114356T1 (en) SUSPENSION VIRUS INHIBITIONS C
MXPA06013411A (en) Process for the production of an influenza vaccine.
SG179082A1 (en) Method for the preparation of an influenza virus
MX349119B (en) Inactivated dengue virus vaccine.
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
WO2009135199A3 (en) Vaccine compositions and methods
WO2009080806A3 (en) Modified influenza virus
HK1207871A1 (en) Peptides derived from viral proteins for use as immunogens and dosage reactants
UA103330C2 (en) Vaccine against infectious bronchitis derived from ib-qx-like strains
WO2013058484A3 (en) Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same
WO2011007339A3 (en) Chimeric foot and mouth disease viruses
MX387420B (en) VIRUS PRODUCTION IN CELL CULTURES.
WO2009126308A3 (en) Compositions and methods for vaccine and virus production
WO2010028072A3 (en) Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use
WO2009152519A3 (en) Novel antiviral peptides against influenza virus
WO2014008475A3 (en) Compositions and methods related to viral vaccines